Clincosm LogoSign in Get a demo

Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

Sponsor
Universitaire Ziekenhuizen Leuven (Other)
Overall Status
Completed
CT.gov ID
NCT01788319
Collaborator
(none)
30
Enrollment
1
Location
1
Arm
27.9
Duration (Months)
1.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.

Condition or Disease Intervention/Treatment Phase
  • Procedure: lasertrabeculoplasty
 N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Dec 1, 2014
Actual Study Completion Date :
Jun 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: lasertrabeculoplasty

Procedure: lasertrabeculoplasty
Other Names:
  • Conventional (532nm)

    		•

    Outcome Measures

    Primary Outcome Measures

    1. to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm) [one year of follow-up]

    Secondary Outcome Measures

    1. Secondary the complication rate between the two techniques will be compared [one year of follow up]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 90 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • individuals over 18 years old

    • willing to sign an informed consent and able to comply the requirements of the study

    • having no other ocular diseases besides glaucoma

    Exclusion Criteria:

    • history of ocular trauma

    • intraocular surgery (except for phaco)

    • pigment dispersion and exfoliation glaucoma

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Ophthalmology, UZLeuven Leuven Belgium

    Sponsors and Collaborators

    • Universitaire Ziekenhuizen Leuven

    Investigators

    • Principal Investigator: Evelien Vandewalle, MD, PhD, Universitaire Ziekenhuizen Leuven

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Universitaire Ziekenhuizen Leuven
    ClinicalTrials.gov Identifier:
    NCT01788319
    Other Study ID Numbers:
    • S55194
    First Posted:
    Feb 11, 2013
    Last Update Posted:
    Jun 23, 2015
    Last Verified:
    Feb 1, 2013
    Keywords provided by Universitaire Ziekenhuizen Leuven
    laser trabeculoplasty
    glaucoma
    Additional relevant MeSH terms:
    Glaucoma
    Glaucoma, Open-Angle

    Study Results

    No Results Posted as of Jun 23, 2015